Figure 3.
S100A10 can regulate indigitation through down-regulating Na+ current; S100A10 mediates depression-like state by affecting the localization of 5-HT1B receptor on cell surface; S100A10 supresses apoptosis through inhibiting Bcl-2-associated death promoter (BAD) activation; DLC1 competitively binds S100A10 with annexin A2 to inhibit invasion and metastasis of NSCLC; Ras and TAMs promote tumor progression via regulating S100A10 expression.